In conclusion, for T2DM mice, we found that rMSA treatments increased the serum albumin levels and then improved the blood glucose homeostasis, including glucose tolerance, insulin sensitivity, GSIS, and FBGL. This evidence concerns the gene ALB and type 2 diabetes mellitus.